Taipei Medical University Hospital — Taipei

Public research footprint of Taipei Medical University Hospital, compiled from the ClinicalTrials.gov public registry.

319

Registered studies

128

Active

Recruiting now

117

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Non-Small Cell Lung Cancer · Limited-stage Small Cell Lung Cancer (LS-SCLC) · Non-small Cell Lung Cancer, Non-squamous

Recently updated registry entries

NCT06305754 — Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy… (Active Not Recruiting)
NCT07573176 — A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major… (Recruiting)
NCT06077760 — A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Taipei Medical University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.